Aurinia Pharm Ord (AUPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 80,213 | 83,433 | 48,875 | 94,172 | 231,900 |
| Marketable Securities | 317,784 | 275,043 | 301,614 | 295,218 | 234,178 |
| Receivables | 41,454 | 36,544 | 24,089 | 13,483 | 15,414 |
| Inventories | 45,690 | 39,228 | 39,705 | 24,752 | 19,326 |
| Other current assets | 1,080 | 1,129 | 1,031 | 1,334 | 796 |
| TOTAL | $491,967 | $446,596 | $424,800 | $442,539 | $513,324 |
| Non-Current Assets | |||||
| PPE Net | 2,111 | 2,731 | 3,354 | 3,650 | 4,418 |
| Investments And Advances | 0 | 0 | 201 | 0 | 0 |
| Intangibles | 3,761 | 4,355 | 4,977 | 6,425 | 8,404 |
| Other Non-Current Assets | 253,748 | 96,963 | 114,730 | 18,246 | 17,221 |
| TOTAL | $259,620 | $104,049 | $123,262 | $28,321 | $30,043 |
| Total Assets | $751,587 | $550,645 | $548,062 | $470,860 | $543,367 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,313 | 5,187 | 4,327 | 39,990 | 34,947 |
| Accrued Expenses | 66,621 | 64,971 | 50,062 | N/A | N/A |
| Other current liabilities | 2,480 | 1,531 | 2,388 | 2,033 | 4,450 |
| TOTAL | $93,724 | $97,763 | $77,188 | $46,107 | $40,646 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,720 | 11,002 | 4,813 | 3,148 | 190 |
| Other Non-Current Liabilities | 11,562 | 15,151 | 17,441 | 19,318 | 23,630 |
| TOTAL | $76,532 | $75,404 | $92,920 | $19,318 | $23,630 |
| Total Liabilities | $170,256 | $173,167 | $170,108 | $65,425 | $64,276 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 132,971 | 137,339 | 144,618 | 142,577 | 141,654 |
| Common Shares | 1,120,035 | 1,187,696 | 1,200,218 | 1,185,309 | 1,177,051 |
| Retained earnings | -649,368 | -936,570 | -942,322 | -864,302 | -756,122 |
| Other shareholders' equity | -599 | -647 | -730 | -1,061 | -852 |
| TOTAL | $581,331 | $377,478 | $377,954 | $405,435 | $479,091 |
| Total Liabilities And Equity | $751,587 | $550,645 | $548,062 | $470,860 | $543,367 |